These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9580265)

  • 1. [Histomorphometry study of the effect of an inhibitor of 5-alpha reductase on the coating of human prostate explants in tissue culture].
    López Muñoz A; Larrán Lopez J; Salido Peracaula M; Aparicio Patino J; Vilches Troya J
    Actas Urol Esp; 1998 Jan; 22(1):11-6. PubMed ID: 9580265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of the effect of a 5-alpha-reductase inhibitor on cultured explants of human prostate].
    López Munñoz A; Lárran López J; Aparicio Patino J; Muñoz de la Pascua MC; Salido Peracaula M; de Palacio Rubio ML; Romero Gutiĕrrez L; Rodríguez Vallejoo JM
    Actas Urol Esp; 1996 Apr; 20(4):316-22; discussion 323. PubMed ID: 8801791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
    Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate.
    Yamashita A; Hayashi N; Sugimura Y; Cunha GR; Kawamura J
    Prostate; 1996 Jul; 29(1):1-14. PubMed ID: 8685049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate.
    Span PN; Völler MC; Smals AG; Sweep FG; Schalken JA; Feneley MR; Kirby RS
    J Urol; 1999 Jan; 161(1):332-7. PubMed ID: 10037433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of finasteride (Proscar MSD) on seminal composition, prostate function and fertility in male dogs.
    Iguer-Ouada M; Verstegen JP
    J Reprod Fertil Suppl; 1997; 51():139-49. PubMed ID: 9404280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a 5 alpha-reductase inhibitor, finasteride, on the developing prostate and testis of a marsupial.
    Ryhorchuk AR; Shaw G; Butler CM; Renfree MB
    J Androl; 1997; 18(2):123-30. PubMed ID: 9154506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5alpha-reductase inhibitors.
    Rittmaster RS
    J Androl; 1997; 18(6):582-7. PubMed ID: 9432130
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride.
    Makridakis N; Reichardt JK
    J Mol Endocrinol; 2005 Jun; 34(3):617-23. PubMed ID: 15956333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of finasteride on vascular endothelial growth factor.
    Häggström S; Tørring N; Møller K; Jensen E; Lund L; Nielsen JE; Bergh A; Damber JE
    Scand J Urol Nephrol; 2002; 36(3):182-7. PubMed ID: 12201932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is tumour grade applicable to finasteride-treated prostate cancer?].
    Molinié V; Ruffion A; Allory Y; Leroy X; Cochand Priollet B; Paraf F; de la Taille A
    Prog Urol; 2005 Jun; 15(3):387-91. PubMed ID: 16097140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
    Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
    Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5 alpha-reductase inhibition by a new synthetic steroid (PM-9) in cultures of Penicillium crustosum.
    Cabeza M; Quiroz A; Bratoeff E; García G; Ramírez E; Flores E
    Proc West Pharmacol Soc; 2002; 45():164-5. PubMed ID: 12434569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta-sitosterol as inhibitor of 5 alpha-reductase in hamster prostate.
    Cabeza M; Bratoeff E; Heuze I; Ramírez E; Sánchez M; Flores E
    Proc West Pharmacol Soc; 2003; 46():153-5. PubMed ID: 14699915
    [No Abstract]   [Full Text] [Related]  

  • 15. A model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride.
    Gisleskog PO; Hermann D; Hammarlund-Udenaes M; Karlsson MO
    Clin Pharmacol Ther; 1998 Dec; 64(6):636-47. PubMed ID: 9871428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5alpha-Reductase inhibitor treatment of prostatic diseases: background and practical implications.
    Dörsam J; Altwein J
    Prostate Cancer Prostatic Dis; 2009; 12(2):130-6. PubMed ID: 19030020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
    Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
    Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the regulation of prostatic oxytocin by gonadal steroids in the rat.
    Jenkin L; Nicholson HD
    J Androl; 1999; 20(1):80-7. PubMed ID: 10100477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of prostate cancer with finasteride.
    Rubin MA; Kantoff PW
    N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14561801
    [No Abstract]   [Full Text] [Related]  

  • 20. [5-alpha-reductase inhibitors].
    De Jaegher K; Kozyreff P; Claes H
    Acta Urol Belg; 1994 Dec; 62(4):23-31. PubMed ID: 7540795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.